As of September 2024, Egetis Therapeutics AB has a market cap of $149.84M. This makes Egetis Therapeutics AB the world's 18954th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $147.87M | -5.91% |
2023 | $157.17M | -21.41% |
2022 | $199.98M | 5.81% |
2021 | $189.00M | -10.17% |
2020 | $210.40M | -62.65% |
2019 | $563.32M | 31.15% |
2018 | $429.53M | -16.67% |
2017 | $515.44M | 4.57% |
2016 | $492.91M | -63.16% |
2015 | $1.34B | 90.00% |
2014 | $704.16M | 103.16% |
2013 | $346.60M | 71.59% |
2012 | $202.00M | - |